Drugs.com
@drugs.com
Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
#VabysmoVsEylea: Both eye injections treat AMD & DME. Vabysmo (2022) targets VEGF/Ang-2, Eylea (2011) targets VEGF/P1GF. Both got updates: Eylea HD (2023) & Vabysmo ready-to-use (2024). Eylea approved for more conditions. https://buff.ly/3CrZuY4
February 12, 2025 at 5:25 PM
#VabysmoVsEylea: Both eye injections treat AMD & DME. Vabysmo (2022) targets VEGF/Ang-2, Eylea (2011) targets VEGF/P1GF. Both got updates: Eylea HD (2023) & Vabysmo ready-to-use (2024). Eylea approved for more conditions. https://buff.ly/3CrZuY4
#Dupixent (dupilumab) can help treat multiple conditions by fighting inflammation and is approved for:
✓ Eczema
✓ Asthma
✓ Chronic sinus issues with nasal polyps
✓ COPD
✓ Eosinophilic esophagitis
✓ Prurigo nodularis
Dupixent targets specific proteins (IL-4 and IL-13) that cause inflammation.
✓ Eczema
✓ Asthma
✓ Chronic sinus issues with nasal polyps
✓ COPD
✓ Eosinophilic esophagitis
✓ Prurigo nodularis
Dupixent targets specific proteins (IL-4 and IL-13) that cause inflammation.
January 30, 2025 at 5:25 PM
#Dupixent (dupilumab) can help treat multiple conditions by fighting inflammation and is approved for:
✓ Eczema
✓ Asthma
✓ Chronic sinus issues with nasal polyps
✓ COPD
✓ Eosinophilic esophagitis
✓ Prurigo nodularis
Dupixent targets specific proteins (IL-4 and IL-13) that cause inflammation.
✓ Eczema
✓ Asthma
✓ Chronic sinus issues with nasal polyps
✓ COPD
✓ Eosinophilic esophagitis
✓ Prurigo nodularis
Dupixent targets specific proteins (IL-4 and IL-13) that cause inflammation.